Revolution Medicines director Elizabeth M. Anderson disposes of $1,949,321.86 in common shares
Bitget2026/09/24 22:00- Elizabeth M. Anderson, director, cut her direct stake in Revolution Medicines common stock to 4,333 shares on Sep. 22, 2026.
- The change followed option exercise of 5,070 shares at USD 1.12, then sales totaling 10,143 shares at USD 191.8521-USD 195.15.
- Derivative holdings fell to 1,095 stock options exercisable at USD 1.12, expiring Apr. 19, 2028.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
